Rezvani A H, Garbutt J C, Shimoda K, Garges P L, Janowsky D S, Mason G A
Skipper Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill 27599-7175.
Alcohol Clin Exp Res. 1992 Apr;16(2):326-30. doi: 10.1111/j.1530-0277.1992.tb01385.x.
Experiments were performed to characterize the acute effect of different doses of a novel thyrotropin-releasing hormone (TRH) analogue (TA-0910) on ethanol intake in rats. Selectively bred alcohol-preferring (P) rats received a single intraperitoneal injection of normal saline or 0.083, 0.25 and 0.75 mg/kg of TA-0910 at 9:30 AM, and their consumption of ethanol, water, and food was measured for 24 hr. TA-0910 dose-dependently attenuated ethanol intake and commensurately increased water consumption. Only the highest dose of TA-0910 increased the total caloric intake. TA-0910 did not affect the pharmacokinetics of ethanol. These findings indicate involvement of TRH systems in ethanol preference and suggest that centrally acting TRH analogues may be therapeutic in the treatment of alcoholism.
开展实验以表征不同剂量的新型促甲状腺激素释放激素(TRH)类似物(TA-0910)对大鼠乙醇摄入量的急性影响。选择性培育的嗜酒(P)大鼠于上午9:30接受一次腹腔注射生理盐水或0.083、0.25和0.75 mg/kg的TA-0910,并测量其24小时内的乙醇、水和食物消耗量。TA-0910剂量依赖性地减少乙醇摄入量,并相应增加水的消耗量。只有最高剂量的TA-0910增加了总热量摄入。TA-0910不影响乙醇的药代动力学。这些发现表明TRH系统参与了乙醇偏好,并提示中枢作用的TRH类似物可能对酒精中毒治疗具有疗效。